Previous 10 | Next 10 |
2024-02-15 18:38:05 ET Three otherwise innocuous words -- reverse stock split -- can cause much disappointment and even sow panic in an investor community. Shareholders of clinical-stage biotech Agenus (NASDAQ: AGEN) experienced this vividly on Thursday when their company announced ...
A look at the top 10 most actives in the United States SoundHound AI Inc. (SOUN) rose 62.5% to $3.665 on volume of 269,509,234 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 64.1% to $0.105 on volume of 159,463,786 shares Sientra Inc. (SIEN) rose 119.4% to $0.395 on volume of...
2024-02-15 13:58:40 ET More on Agenus, Ginkgo Bioworks, etc. Ginkgo Bioworks At The Intersection Of Cutting-Edge Technology And Financial Disappointment Agenus: Taking Advantage Of The Risk-Reward Opportunity Agenus: 2024 May Finally Be The Year For A Major Turnaroun...
Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design PR Newswire BOSTON and LEXINGTON, Mass. , Feb. 15, 2024 /PRNewswire/ -- The Defense Threat Reduction Agency...
2024-02-09 12:14:22 ET More on Moderna Moderna: Fade 2025 Outlook Moderna's Post-Covid Hangover Might Persist For A Few More Years Moderna, Inc. (MRNA) JPMorgan 42nd Annual Healthcare Conference Transcript Moderna RSV vaccine lags rival shots in long-term eff...
2024-02-08 15:32:06 ET More on GSK, Moderna, etc. Pfizer: The 6.3% Yield Is A Appealing Pfizer: Simply Too Cheap To Ignore Pfizer Is Down 54% From Highs, Now Yields 6.1% GSK stock traded in green for seventh straight session GSK RSV vaccine under FDA ...
2024-02-06 08:46:40 ET More on GSK GSK plc (GSK) Q4 2023 Earnings Call Transcript GSK plc 2023 Q4 - Results - Earnings Call Presentation GSK: Robust Earnings Report Expected, 2024 Outlook Is Key GSK blood cancer therapy nearly triples survival in late stage t...
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced that Dr. Garo Armen, Chairman and CEO, will participate in a fireside chat and investor one-on-ones at the upcoming Oppenheimer Healthca...
2024-01-30 12:20:27 ET More on GSK GSK: Robust Earnings Report Expected, 2024 Outlook Is Key GSK plc (GSK) 42nd Annual JP Morgan Healthcare Conference (Transcript) AbbVie Vs. GSK: Dual Dominance In Pharma GSK enters licensing deal with Elegen Watch GS...
2024-01-24 10:22:27 ET Summary Agenus Inc. has unveiled promising data from the NEST-1 study, showing the potential of the combination of botensilimab and balstilimab in colorectal cancer treatment. The combination demonstrated significant tumor regression and the elimination of c...
News, Short Squeeze, Breakout and More Instantly...
Extended BOT/BAL Therapy Yields Pronounced Improvements in Tumor Reductions Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced results from an investigator-sponsored trial (IST) of botensilim...
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced that the Cancer Therapy Evaluation Program (CTEP) is accepting Letters of Intent (LOIs) to conduct clinical studies using botensilimab (BOT), a huma...
2024-06-27 01:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...